Contraindications across the group commonly include pregnancy or breastfeeding and being under 18, with additional considerations such as active or recent cancer (CJC + Ipamorelin, IGF-1 LR3), active malignancy (Sermorelin), uncontrolled blood sugar disorders (CJC + Ipamorelin), uncontrolled metabolic or endocrine disorders (IGF-1 LR3, MOTS-C), severe liver or kidney disease (MOTS-C), autoimmune disorders requiring careful metabolic regulation (MOTS-C), and use of insulin or oral hypoglycaemic medications due to hypoglycaemia risk (MOTS-C)
Chronic stress raises cortisol, which can block weight loss progress
The beneficial effects of berberine on blood sugar "may be comparable to a moderate dose of metformin," he said
Established Safety Profile CagriSema Builds on semaglutide's 7+ year post-marketing safety record and over 25,000 clinical trial participants
Dermatologic research applications: Melanotan I has been evaluated in clinical research involving pigmentation disorders and light sensitivity conditions
These studies contribute to a broader understanding of physiological energy control mechanisms
